If you are launching a new generic pharmaceutical company and product or product line in the United States, the task can be daunting. Competition is so fierce for generic companies that it is not unusual to see innovator products come off patent with prices in the hundreds of dollars and quickly descend below ten dollars for their generic versions. In this environment, you need a disciplined and expedient launch-planning process.
Prescription Analytics can help you manage the vital financial details of contracting processes required to gain access to patients through commercial and government contracting. Processes are diverse and multi-dimensional. We help you get comfortable with the complicated.
There’s a lot to think about: speed to market, U.S. supply chains and distribution channels, expanding a product catalog while maintaining profitability, reaching the widest possible audience and more. We help you stay on top of it all.